Summary
Symphogen is a privately-owned biotech company focused on oncology and immuno-oncology.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Martin Olin
CEO
Bernhard Ehmer
Chairman
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy